Mon, Sep 15, 2014, 10:36 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • kinkey_boots kinkey_boots Nov 24, 2013 10:50 AM Flag

    Scaled results IF that happens ,rehdvm2004

    a banner day for headlines at INSM and elsewhere when that happens.

    IF that happens.Your spin MAY happen and MAY NOT.It's blinded and everyone involved knows it.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • The point that I find encouraging is that KN Olivier enrolled only 90 patients. Not the 100 that was agreed to with the FDA. So that suggests two outcomes. That Arikace was not knocking down NTM significantly and they stopped/terminated the study; or the outcome was so convincing that they achieved statistical significance with 90 patients and ten more would not have affected the conclusion about the clinical trial. I tend to lean towards the latter because of looking at the results of so many efficacy studies across the years beginning with Baxter Healthcare in the mid 1970s. Remember INSM committed to spending $15-18 for those 100 patients to get an orphan, totally proprietary prescription label into the late 2020s. If Arikace was NOT achieving the anticipated efficacy, they would have quit after 50 patients. They did not. Now they are focused on the EAP clinical trial and cutting off that 6 month pre-enrollment criteria.

      GLTAL

      Sentiment: Strong Buy

 
INSM
13.37-0.21(-1.55%)Sep 15 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Avanir Pharmaceuticals, Inc.
NasdaqGSMon, Sep 15, 2014 4:00 PM EDT
Tesla Motors, Inc.
NasdaqGSMon, Sep 15, 2014 4:00 PM EDT